Associated Factors for Infant Pertussis Death in Sabah, Malaysia
Main Article Content
Abstract
Introduction: Pertussis remains a significant public health concern globally, particularly for infants, who are at higher risk of severe disease and mortality. Despite the availability of vaccines, pertussis cases and deaths persist, with recent resurgences reported worldwide. This study aims to identify factors associated with infant pertussis mortality in Sabah, Malaysia, to inform targeted interventions and public health strategies. Materials and methods: A cross-sectional study design was employed, utilizing communicable disease notification data from 2016 to 2020 in Sabah. Descriptive and statistical analyses were conducted to investigate the association between sociodemographic characteristics, pertussis vaccination status, and infant pertussis death. Results: A total of 323 infant pertussis cases were included in the study. Factors significantly associated with pertussis mortality included gender and pertussis vaccination status. Female infants had 2.67 times higher odds of mortality (95% CI: 1.132, 6.288, p = 0.025), while infants fully vaccinated for age had a 79.4% reduced likelihood of death (AOR: 0.206, 95% CI: 0.074, 0.576, p = 0.003). Conclusion: Our study underscores the importance of gender-sensitive healthcare and complete vaccination in reducing infant pertussis mortality. Strategies emphasizing gender-based approaches, timely vaccination and early protective measures are essential to mitigate pertussis-related deaths in Sabah.
Downloads
Article Details
References
CDC. Centers for Disease Control and Prevention. About Whooping Cough (Pertussis). 2019 [cited 2022 May 25]. Available from: https://www.cdc.gov/pertussis/about/index.html
Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev. 2016;29(3):449–86. https://doi.org/10.1128/CMR.00083-15.
Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Front Immunol. 2019;10:1344. https://doi.org/10.3389/fimmu.2019.01344.
Kardas-Nelson M. Despite high rates of vaccination, pertussis cases are on the rise. Is a new vaccination strategy needed? BMJ. 2019;365:l4460. https://doi.org/10.1136/bmj.l4460.
WHO. World Health Organization. Pertussis. 2019 [cited 2022 May 26]. Available from: https://www.who.int/health-topics/pertussis
Crowcroft NS, Johnson C, Chen C, Li Y, Marchand-Austin A, Bolotin S, et al. Under-reporting of pertussis in Ontario: a Canadian Immunization Research Network (CIRN) study using capture–recapture. PLoS One. 2018;13(5):e0195984. https://doi.org/10.1371/journal.pone.0195984.
Schielke A, Takla A, von Kries R, Wichmann O, Hellenbrand W. Marked Underreporting of Pertussis Requiring Hospitalization in Infants as Estimated by Capture–Recapture Methodology, Germany, 2013–2015. Pediatr Infect Dis J. 2018;37(2):e47–e52.
Solano R, Crespo I, Fernández M, Valero C, Álvarez M, Godoy P, et al. Underdetection and underreporting of pertussis in children attended in primary health care centers: Do surveillance systems require improvement? Am J Infect Control. 2016;44(5):565–9. https://doi.org/10.1016/j.ajic.2016.03.033.
Rocha G, Soares P, Soares H, Pissarra S, Guimarães H. Pertussis in the newborn: certainties and uncertainties in 2014. Paediatr Respir Rev. 2015;16(2):112–8. https://doi.org/10.1016/j.prrv.2014.01.004.
von Koenig CHW, Guiso N. Global burden of pertussis: signs of hope but need for accurate data. Lancet Infect Dis. 2017;17(9):889–90. https://doi.org/10.1016/S1473-3099(17)30357-2.
Domenech de Cellès M, Magpantay FMG, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc R Soc B Biol Sci. 2016;283(1822):20152309.
WHO. World Health Organization. Pertussis reported cases and incidence: Malaysia. 2024 [cited 2024 May 26]. Available from: https://immunizationdata.who.int/pages/incidence/PERTUSSIS.html
Ministry of Health Malaysia (MOH). Malaysia Health Indicators 2020. Putrajaya: Ministry of Health Malaysia; 2021. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Penerbitan%20Utama/HEALTH%20INDICATOR/01_Petunjuk_Kesihatan_2020.pdf.
Mohamed TJ, Fong SM, Nadarajaw T, Choo CM, Yusoff NKN, Nachiappan JP, et al. Burden of pertussis among young infants in Malaysia: a hospital-based surveillance study. Vaccine. 2022;40(35):5241–7. https://doi.org/10.1016/j.vaccine.2022.07.019.
Ting TX, Hashim R, Ahmad N, Abdullah KH. Detection of Bordetella pertussis from clinical samples by culture and end-point PCR in Malaysian patients. Int J Bacteriol. 2013;2013:324136. https://doi.org/10.1155/2013/324136.
Ismail Z. Pertussis resurgence: where have we gone wrong? Proceedings of the 5th Global Congress on Consensus in Pediatrics and Child Health; Xi’an, China; 2016 Mar 3–6.
Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14–7.
Abu-Raya B, Bettinger JA, Vanderkooi OG, Vaudry W, Halperin SA, Sadarangani M, et al. Burden of children hospitalized with pertussis in Canada in the acellular pertussis vaccine era, 1999–2015. J Pediatric Infect Dis Soc. 2020;9(2):118–27. https://doi.org/10.1093/jpids/piy128.
Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J. 2009;28(3):194–8. https://doi.org/10.1097/INF.0b013e31818c9032.
Peer V, Schwartz N, Green MS. A multi-country, multi-year, meta-analytic evaluation of the sex differences in age-specific pertussis incidence rates. PLoS One. 2020;15(4):e0231570. https://doi.org/10.1371/journal.pone.0231570.
Vázquez-Martínez ER, García-Gómez E, Camacho-Arroyo I, González-Pedrajo B. Sexual dimorphism in bacterial infections. Biol Sex Differ. 2018;9(1):1–20.
vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12(2):e1005374. https://doi.org/10.1371/journal.ppat.1005374.
Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, et al. A report on the status of vaccination in Europe. Vaccine. 2018;36(33):4979–92.
Tiwari TSP, Baughman AL, Clark TA. First pertussis vaccine dose and prevention of infant mortality. Pediatrics. 2015;135(6):990–9. https://doi.org/10.1542/peds.2014-2291.
Alghounaim M, Alsaffar Z, Alfraij A, Bin-Hasan S, Hussain E. Whole-cell and acellular pertussis vaccine: reflections on efficacy. Med Princ Pract. 2022;31(4):313–21. https://doi.org/10.1159/000525468.
Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001. Pediatrics. 2005;116(2):e285–94. https://doi.org/10.1542/peds.2004-2759.
Zhu P, Wu D, Wang Y, Liu X, Rodewald LE, Li Y, et al. Effectiveness of DTaP against pertussis in ≤2-year-old children — Linyi Prefecture, Shandong Province, China, 2017–2019. China CDC Wkly. 2023;5(17):374–8. https://doi.org/10.46234/ccdcw2023.071.
WHO. Pertussis vaccines: WHO position paper, August 2015—Recommendations. Vaccine. 2016;34(12):1423–5. https://doi.org/10.1016/j.vaccine.2015.10.136.
Marshall H, Clarke M, Rasiah K, Richmond P, Buttery J, Reynolds G, et al. Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatr Infect Dis J. 2015;34(4):339–45. https://doi.org/10.1097/INF.0000000000000577.
Shi T, Wang L, Du S, Fan H, Yu M, Ding T, et al. Mortality risk factors among hospitalized children with severe pertussis. BMC Infect Dis. 2021;21(1):1057. https://doi.org/10.1186/s12879-021-06732-1.
Mohd Putera NWS, Azman AS, Mohd Zain SN, Yahaya H, Lewis JW, Sahimin N. Current status of infectious diseases among migrants and non-citizens in Malaysia. Trop Biomed. 2023;40(2):138–51.
Qamruddin AA, Xavier G, Zahid SM. Factors associated with tuberculosis mortality in Manjung District, Perak, Malaysia. Malays J Med Sci. 2023;30(3):167.
Lasimbang HB, Tong WT, Low WY. Migrant workers in Sabah, East Malaysia: the importance of legislation and policy to uphold equity on sexual and reproductive health and rights. Best Pract Res Clin Obstet Gynaecol. 2016;36:93–102. https://doi.org/10.1016/j.bpobgyn.2015.08.015.
Steven MC, Ibrahim MYH, Karim HA, Dhanaraj P, Mansin KA. Barriers and drivers towards the use of childhood vaccination services by undocumented migrant caregivers in Sabah, Malaysia: a qualitative analysis. Int J Nurs Health Sci. 2021;15(8):247–56.
Malaysian Red Crescent Society (MRCS). MyVac. Malaysia Vaccine Support Volunteers. 2021 [cited 2024 Jan 5]. Available from: https://www.myvac.com.my/.
The Star. MyVac volunteers happy, proud to serve community, country. The Star. 2021 Jun 23.
Salleh H, Avoi R, Abdul Karim H, Osman S, Dhanaraj P, Ab Rahman MA. A behavioural-theory-based qualitative study of the beliefs and perceptions of marginalised populations towards community volunteering to increase measles immunisation coverage in Sabah, Malaysia. Vaccines (Basel). 2023;11(6):1056. https://doi.org/10.3390/vaccines11061056.
CodeBlue. MOH mulls lower vaccination fees or free doses for non-Malaysian kids. CodeBlue. 2023 [cited 2023 Jan 5]. Available from: https://codeblue.galencentre.org/2023/05/31/moh-mulls-lower-vaccination-fees-or-free-doses-for-non-malaysian-kids/.
Kusnin F. Immunisation programme in Malaysia. In: Proceedings of Vaccinology 2017-III International Symposium for Asia-Pacific Experts; 2017.
Stevens AJ. How can we meet the health needs of child refugees, asylum seekers and undocumented migrants? Arch Dis Child. 2019;104(11):1049–52. https://doi.org/10.1136/archdischild-2018-316614.
Stubbe Østergaard L, Norredam M, Mock-Munoz de Luna C, Blair M, Goldfeld S, Hjern A. Restricted health care entitlements for child migrants in Europe and Australia. Eur J Public Health. 2017;27(5):869–73. https://doi.org/10.1093/eurpub/ckx083.
Suphanchaimat R, Kunpeuk W, Phaiyarom M, Nipaporn S. The effects of the health insurance card scheme on out-of-pocket expenditure among migrants in Ranong Province, Thailand. Risk Manag Healthc Policy. 2019;12:317–30. https://doi.org/10.2147/RMHP.S219571.
Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1–44.
CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131–5.